Literature DB >> 20338684

Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility.

Xuekang Yang1, Desheng Wang, Wei Dong, Zhenshun Song, Kefeng Dou.   

Abstract

Na(+)/H(+) exchanger 1 (NHE1) plays a significant role in tumor metastasis. However, the exact mechanisms by which NHE1 mediates cell invasion and migration, especially in hepatocellular carcinoma (HCC), are not yet known. In the current study, we show for the first time that the inhibition of NHE1 by 5-(N-ethyl-N-isopropyl) amiloride (EIPA) is able to suppress migration and invasion of HepG2 cells under hypoxic conditions. In addition, hypoxia activated ERK1/2, which in turn promoted the production of MMP-2, MMP-9 and VEGF. EIPA's suppressive role was determined to act through down-regulation of MMP-2, MMP-9 and VEGF in an ERK1/2 dependent manner. The data demonstrate that NHE1 plays a role in HCC invasion and that NHE1 may be a potential therapeutic target for HCC treatment. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338684     DOI: 10.1016/j.canlet.2010.03.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

Review 1.  Role of pHi, and proton transporters in oncogene-driven neoplastic transformation.

Authors:  Stephan Joel Reshkin; Maria Raffaella Greco; Rosa Angela Cardone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

2.  NHE1 has a notable role in metastasis and drug resistance of T-cell acute lymphoblastic leukemia.

Authors:  Ehtisham Altaf; Xiaoxing Huang; Jie Xiong; Xiangyong Yang; Xinzhou Deng; Meng Xiong; Lu Zhou; Shan Pan; Wen Yuan; Xinran Li; Ling Hao; Kingsley Miyanda Tembo; Ruijing Xiao; Qiuping Zhang
Journal:  Oncol Lett       Date:  2017-08-03       Impact factor: 2.967

3.  Urokinase plasminogen activator receptor induced non-small cell lung cancer invasion and metastasis requires NHE1 transporter expression and transport activity.

Authors:  J J Provost; D Rastedt; J Canine; T Ngyuen; A Haak; C Kutz; N Berthelsen; A Slusser; K Anderson; G Dorsam; M A Wallert
Journal:  Cell Oncol (Dordr)       Date:  2012-01-31       Impact factor: 6.730

4.  Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition.

Authors:  Xiao-lin Zhu; Yan-li Wang; Jie-peng Chen; Li-li Duan; Pei-fang Cong; Ying-chun Qu; Jesse Li-Ling; Mei-xia Zhang
Journal:  Tumour Biol       Date:  2014-02

Review 5.  Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.

Authors:  Katharine A White; Bree K Grillo-Hill; Diane L Barber
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

6.  Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.

Authors:  Larry Fliegel
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

7.  Permissive role of Na+/H+ exchanger isoform 1 in migration and invasion of triple-negative basal-like breast cancer cells.

Authors:  Xiuju Li; Larry Fliegel
Journal:  Mol Cell Biochem       Date:  2022-01-27       Impact factor: 3.396

Review 8.  Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment.

Authors:  Anne Poder Andersen; José M A Moreira; Stine Falsig Pedersen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

Review 9.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

10.  A cell-permeant amiloride derivative induces caspase-independent, AIF-mediated programmed necrotic death of breast cancer cells.

Authors:  Leonardo J Leon; Nagarekha Pasupuleti; Fredric Gorin; Kermit L Carraway
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.